FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 350:1595-1597 April 15, 2004 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Grimwade, D. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Bullinger, L. Related Article by Valk, P. J.M. PubMed Citation

Two articles in this issue of the Journal tell a similar story: primary acute myeloid leukemia (AML) may be divided into subclasses according to gene-expression profiles. Given the number of articles that describe the correlative and predictive usefulness of array-based molecular classifications, especially in leukemias, these outcomes no longer elicit surprise. But perhaps they should — not only because of their clinical usefulness, as outlined in the editorial by Grimwade and Haferlach (pages 1676–1678), but also because of the rapid pace at which expression genomics is changing the conduct of clinical research.

Not too long ago, a single molecular marker, . . . [Full Text of this Article]

Source Information

From the Genome Institute of Singapore, Singapore.

This article has been cited by other articles:

• Larrouy, D., Barbe, P., Valle, C., Dejean, S., Pelloux, V., Thalamas, C., Bastard, J.-P., Le Bouil, A., Diquet, B., Clement, K., Langin, D., Viguerie, N. (2008). Gene expression profiling of human skeletal muscle in response to stabilized weight loss. Am. J. Clin. Nutr. 88: 125-132 [Abstract] [Full Text]  
• Ioannidis, J. P. A. (2007). Is Molecular Profiling Ready for Use in Clinical Decision Making?. The Oncologist 12: 301-311 [Abstract] [Full Text]  
• Horvath, S., Zhang, B., Carlson, M., Lu, K. V., Zhu, S., Felciano, R. M., Laurance, M. F., Zhao, W., Qi, S., Chen, Z., Lee, Y., Scheck, A. C., Liau, L. M., Wu, H., Geschwind, D. H., Febbo, P. G., Kornblum, H. I., Cloughesy, T. F., Nelson, S. F., Mischel, P. S. (2006). Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. USA 103: 17402-17407 [Abstract] [Full Text]  
• Anensen, N., Oyan, A. M., Bourdon, J.-C., Kalland, K. H., Bruserud, O., Gjertsen, B. T. (2006). A Distinct p53 Protein Isoform Signature Reflects the Onset of Induction Chemotherapy for Acute Myeloid Leukemia.. Clin. Cancer Res. 12: 3985-3992 [Abstract] [Full Text]  
• Reis-Filho, J S, Westbury, C, Pierga, J-Y (2006). The impact of expression profiling on prognostic and predictive testing in breast cancer.. J. Clin. Pathol. 59: 225-231 [Abstract] [Full Text]  
• Kittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G., Garcia, J. G. N., Hare, J. M. (2005). Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics 21: 299-307 [Abstract] [Full Text]  
• Kittleson, M. M., Ye, S. Q., Irizarry, R. A., Minhas, K. M., Edness, G., Conte, J. V., Parmigiani, G., Miller, L. W., Chen, Y., Hall, J. L., Garcia, J. G.N., Hare, J. M. (2004). Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy. Circulation 110: 3444-3451 [Abstract] [Full Text]  
• Dubinett, S. M., Elashoff, D., Meyerson, M. (2004). Assessing Prognosis in Non-Small-Cell Lung Cancer: Avenues to a More Complete Picture?. JCO 22: 3209-3211 [Full Text]  
• (2004). Gene-Expression Profiling Predicts Prognosis of AML. JWatch General 2004: 2-2 [Full Text]